Sony Interactive Entertainment has revealed that number of PS2 classics for PS Plus Premium Classics over the next few months, beginning with Gitaroo Man this month. In addition, July will see the ...

During the State of Play showcase, Sony revealed three classic PS2 games coming to PlayStation Plus Premium over the next three months, as well as a day one Game Catalog title for PlayStation 5.

One of the lowkey better moments during these recent State of Plays has been Sony confirming some upcoming retro content for its PS Plus Premium subscription tier. And we actually got some PS2 bangers ...

Strong revenue growth is testament to Mindgate’s status as a leading software provider for corporate payments. A 43% increase in turnover in FY24 compared with the previous financial year was driven ...

The Lemokey L1 HE is one pricey keyboard, but you certainly get a lot for your money–incredible build quality and a raft of high-quality features. If money’s no object and you want a premium keyboard, ...

The remaining 30% stake in the digital payments infrastructure company is held by its cofounders George Sam and Guhan Muthusamy, who will remain at the helm PayU CEO Anirban Mukherjee told ET that the ...

Historically, I tend to gravitate toward upright vacuums. They have really powerful suction and are commonly stocked with features I like, including LED headlights, tangle-free or self-cleaning brush ...

Google Cloud’s Universal Ledger (GCUL) was first announced in March with CME Group as a blockchain built for finance. Google's Rich Widmann says GCUL will support Python-based smart contracts and ...

Tristan Jurkovich began his career as a journalist in 2011. His childhood love of video games and writing fuel his passion for archiving this great medium’s history. He dabbles in every genre, but ...

Keyboard specialist Keychron has announced that the flagship model from its Lemokey sub-brand has begun shipping. The Lemokey L1 HE magnetic wireless keyboard is an 86-key design with open‑source ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and compared the use of single agent vs doublet immunotherapy in the PD-L1–low ...